Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, LIC

CyCognito Partners With Eviden to Bolster Exposure Management in the Enterprise


CyCognito's comprehensive EASM platform now enables Eviden customers to efficiently identify, prioritize, and remediate vulnerabilities

PALO ALTO, Calif., March 6, 2024 /PRNewswire/ --  CyCognito today announced a strategic partnership with Eviden, the Atos Group business leading in digital, cloud, big data and security. The partnership aims to offer its leading External Attack Surface Management platform (EASM) to Eviden's extensive customer roster worldwide as a foundation to their broader Exposure Management solutions.

Organization's external attack surface is vast and ever-growing, containing large volumes of unknown and exposed internet-facing assets?from servers and applications to cloud resources and domains. Each of these assets could be vulnerable, leaving a back door open for bad actors. Current risk assessment and monitoring solutions simply aren't up to the challenge. This partnership between CyCognito, the leading EASM provider, and Eviden will create a category-defining managed offering.

Through this partnership, customers will benefit from an end-to-end vulnerability and threat management service which includes the following values:

"Our strategic partnership with Eviden is a giant leap in helping more and more businesses worldwide protect their continuously changing attack surfaces and threat landscape," said Randy Streu, SVP Channels & Alliances, CyCognito. "By partnering with Eviden, our joint customers get the combined power of the CyCognito platform with the expert services delivered by Eviden's cyber security solutions, such as the Eviden AIsaac Cyber Mesh platform. This in turn helps them identify, prioritize, and remediate threat exposures end to end, preemptively addressing potential threats and strengthening their security posture."

CyCognito is a member of "Scaler", the Eviden Accelerator for Startups, which drives high-velocity, customer-centric, open innovation within Eviden's core areas: AI, Security, Quantum, & NZT. This unique ecosystem engages technology start-ups/scale-ups, specialist industry players, and strategic partners to help accelerate customers' value creation, optimizing go-to-market, and speeding up business execution.

About CyCognito
CyCognito is an exposure management platform that reduces risk by discovering, testing and prioritizing security issues. The platform scans billions of websites, cloud applications and APIs and uses advanced AI to identify the most critical risks and guide remediation. Emerging companies, government agencies and Fortune 500 organizations rely on CyCognito to secure and protect from growing threats. For more information, visit https://www.cycognito.com/.

SOURCE CyCognito


These press releases may also interest you

at 08:20
Merck , known as MSD outside of the United States and Canada, and Orion Corporation ("Orion") today announced that notice has been provided of the mutual exercise of an option to convert the companies' ongoing co-development and co-commercialization...

at 08:20
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, filed a lawsuit asserting multiple claims for damages against Exact Sciences on June 28, 2024, in federal court in the...

at 08:17
After rocketing to success across social media, boohoo announced The boohoo Collective; an initiative redefining social commerce by integrating 1000s of creators into the shopping experience on boohoo.com. The initiative gives any creator a personal...

at 08:15
Masimo Corporation ("Masimo" or the "Company") today issued a letter to stockholders in connection with the Company's 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee...

at 08:15
Following the CEO transition plan previously announced by Bentley Systems, Incorporated , Nicholas Cumins today takes charge as CEO. Cumins succeeds Greg Bentley, the eldest of the five brothers who founded Bentley Systems, who becomes Executive...

at 08:15
KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study...



News published on and distributed by: